🔍 Technical Entry
• Entry: $104.86 (market price as of latest close)
• Stop: $96.61 (below recent swing low, ~–7.87%)
• Target: $120.39 (analyst average target)
⸻
🧪 Why BSX?
• ✅ Strong Technicals: Breakout from tight consolidation above 21EMA & 50MA
• ✅ Earnings Beast: 6 straight quarters of EPS beats; Q1 2025: +11.5% surprise
• ✅ Raised Guidance: Management raised full-year targets across the board
• ✅ Institutional Momentum: High analyst conviction — 25 “Strong Buy” ratings
• ✅ Sector Tailwinds: Medical device demand + aging population + innovation
⸻
📉 Risk Management
• Keep position size aligned with 1R risk model (e.g. if risking $1,000, buy enough to trigger SL at $96.61)
• Trail stop if price breaks above $108 with volume
DISCLAIMER : The content and materials featured are for your information and education only and are not attended to address your particular personal requirements. The information does not constitute financial advice or recommendation and should not be considered as such. Risk Management is Your Shield! Always prioritise risk management. It’s your best defence against losses.
• Entry: $104.86 (market price as of latest close)
• Stop: $96.61 (below recent swing low, ~–7.87%)
• Target: $120.39 (analyst average target)
⸻
🧪 Why BSX?
• ✅ Strong Technicals: Breakout from tight consolidation above 21EMA & 50MA
• ✅ Earnings Beast: 6 straight quarters of EPS beats; Q1 2025: +11.5% surprise
• ✅ Raised Guidance: Management raised full-year targets across the board
• ✅ Institutional Momentum: High analyst conviction — 25 “Strong Buy” ratings
• ✅ Sector Tailwinds: Medical device demand + aging population + innovation
⸻
📉 Risk Management
• Keep position size aligned with 1R risk model (e.g. if risking $1,000, buy enough to trigger SL at $96.61)
• Trail stop if price breaks above $108 with volume
DISCLAIMER : The content and materials featured are for your information and education only and are not attended to address your particular personal requirements. The information does not constitute financial advice or recommendation and should not be considered as such. Risk Management is Your Shield! Always prioritise risk management. It’s your best defence against losses.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.